Kaléo is a global leader in drug-delivery device technology and auto-injector innovation, helping provide millions of patients and emergency responders with security and peace of mind. Our patented Aerio™ platform, with unmatched capabilities and human factor engineering, powers our portfolio of auto-injectors products, as well as products under development with third parties. Visit us at Kaleo.com to learn more.
| Website | http://www.kaleo.com |
| Revenue | $73.9 million |
| Funding | $165 million |
| Employees | 109 (87 on RocketReach) |
| Founded | 2005 |
| Address | 111 Virginia St, Richmond, Virginia 23219, US |
| Phone | +1 804-545-6360 |
| Technologies |
JavaScript
,
HTML
,
PHP
+34 more
(view full list)
|
| Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Healthcare, Drug Delivery, Medical Devices, Human Factors Engineering (HFE), Biotechnology |
| Competitors | Pfizer, Sanofi, Novo Nordisk, AstraZeneca, Bristol Myers Squibb, Amgen, Boehringer Ingelheim, Teva Pharmaceuticals, Lilly India, Mylan Belgium +43 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Kaléo employee's phone or email?
The Kaléo annual revenue was $73.9 million in 2026.
George Parise is the CFO of Kaléo.
87 people are employed at Kaléo.
Kaléo is based in Richmond, Virginia.
The NAICS codes for Kaléo are [325, 32, 3254, 32541].
The SIC codes for Kaléo are [283, 28].